Dengue fever is known to be a major concern in South America and South-East Asia and its burden on health is becoming an increasing threat within Africa. However, in order to get the proper attention from the government and from investors, it is essential to prove the economic burden of this disease. This is what a new study conducted by Jung-Seok Lee and colleagues attempted to answer for three countries in which the burden on health is most severe: Burkina Faso, Kenya and Cambodia. This was a follow-up study to a similar one that looked at the economic burden of Dengue in Vietnam, Thailand and Colombia. It is important to get the country-specific estimates of economic burden because prices of medication and treatment as well as national health care services can be extremely variable. This variability was expressed in the published results of this study with each case of Dengue costing $13-26 for care in Burkina Faso, $134 in Cambodia, and $23 in Kenya.
The economic burden in each of these countries was not insignificant when compared to malaria (another similar arbovirally transmitted disease) suggesting that these governments may need to consider redistributing some of their resources towards the increasingly pressing threat of Dengue.
-India Robinson
For more information visit: https://www.sciencedaily.com/releases/2019/02/190228141241.htm